First: what AMH actually measures

Anti-Mullerian Hormone (AMH) is a protein produced by the granulosa cells of growing ovarian follicles. It reflects your "functional ovarian reserve," specifically the pool of small growing follicles (about 2 to 5 mm) available for potential ovulation. Because this pool correlates with the total remaining primordial follicle pool, AMH serves as an indirect marker of how many eggs you have left.

AMH naturally declines with age, from roughly 3.0 to 5.0 ng/mL in the early twenties to under 1.0 ng/mL by age 40+. Generally, levels below 1.0 ng/mL are considered low, and below 0.3 ng/mL is considered very low.

The critical distinction: quantity is not quality

This is the single most important point in the AMH conversation, and every major medical body agrees on it.

The American Society for Reproductive Medicine (ASRM) states that AMH reflects "oocyte quantity" and shows only a "weak association with qualitative outcomes such as oocyte quality, clinical pregnancy rates, and live birth rates." They explicitly advise: "Markers of ovarian reserve should not be used as a fertility test for women who are not infertile."

ACOG echoes this: "Serum antimullerian hormone level assessment generally should not be ordered or used to counsel women who are not infertile about their reproductive status."

The UK's NICE guidelines are even more direct: "Do not use AMH levels as a predictor of the likelihood of natural conception."

Think of it this way: AMH tells you roughly how many eggs remain in the machine. But whether the egg that emerges each month is a healthy one depends on egg quality, which is determined primarily by age, not by how many eggs are left.

What the latest studies show

A landmark JAMA study by researchers at the University of North Carolina followed women aged 30 to 44 trying to conceive naturally. Of those with low AMH (below 0.7 ng/mL), 65% conceived within 6 cycles and 84% within 12 cycles. Women with normal AMH (0.7 to 8.4 ng/mL) conceived at virtually the same rates: 62% in 6 cycles and 75% in 12 cycles. The difference was not statistically significant.

A 2024 study in Fertility and Sterility followed approximately 3,150 women and found that low AMH (below 1 ng/mL) was linked to roughly 20% longer time to pregnancy on average, but women with low AMH still conceived across all cycle groups.

A 2024 retrospective study of 504 women concluded: "Low ovarian reserve does not influence natural conception." Low AMH occurred at similar rates in women with unexplained infertility and fertile controls.

In a 2021 meta-analysis of 11 studies and 4,388 women, AMH's predictive value for natural conception was poor, with an area under the curve of 0.59, barely above the 0.50 threshold of pure chance.

A 2025 editorial in Fertility and Sterility titled "Do not measure antimullerian hormone to predict women's fecundity" called routine AMH testing "inappropriate and prone to foster unwarranted anxiety."

What reproductive endocrinologists say

"A low AMH result does not mean infertility," says Dr. Natalie Crawford, MD, a board-certified reproductive endocrinologist. "Whether you have 5 or 20 eggs available in a given month, your body only needs one to ovulate."

Dr. Lucky Sekhon, MD, at RMA of New York, puts it plainly: "Every cycle, a woman ovulates one egg, and it's the quality of that egg, not the quantity of eggs left in the ovaries, that determines the likelihood of conception. AMH is a measure of egg quantity, not egg quality."

Dr. Monica Best at Reproductive Biology Associates adds: "Even if the AMH is less than 1 and the numbers of the eggs are low, the pregnancy rates can be perfectly reasonable, and in fact parallel to those who have better AMH levels."

Dr. Mark Trolice emphasizes: "The younger you are, irrespective of these test results, you should still have success because you still have good quality eggs."

Where AMH does matter

AMH is genuinely useful for one thing: predicting how your ovaries will respond to IVF stimulation medications. If you're planning IVF or egg freezing, the number of eggs retrieved per cycle correlates with AMH. Lower AMH typically means fewer eggs per retrieval, which can affect how many IVF cycles you may need.

But even here, low AMH does not mean treatment is futile. A major study from the SART database of over 5,000 IVF cycles found that patients with ultra-low AMH (0.16 ng/mL) still achieved 13% clinical pregnancy rates per cycle start and 20% live birth rates per transfer.

The ASRM states explicitly: "Extremely low AMH values should not be used to refuse treatment in IVF."

What you can do

Support egg quality through lifestyle: Since quality matters more than quantity, focus on what you can influence. Egg quality is shaped by mitochondrial health, oxidative stress levels, and overall metabolic health.

  • CoQ10 supplementation (400 to 600 mg/day): A randomized controlled trial found that 600 mg/day for 60 days before IVF significantly improved oocyte yield, fertilization rates, and embryo quality in women with diminished ovarian reserve. CoQ10 is an essential cofactor for mitochondrial energy production, and your oocytes are among the most mitochondria-dense cells in your body.
  • DHEA (75 mg/day, physician-supervised): Studies have shown AMH concentrations improved by approximately 60% and mature follicle percentage rose from 54% to 72% with supplementation. This is a hormone and requires medical supervision.
  • Vitamin D: A prospective cohort study found live birth rates differed markedly by vitamin D status: deficient 23.2%, insufficient 27.0%, replete 37.7%. Target serum levels of 30 to 50 ng/mL.
  • Stress management: The LIFE study found that women with high salivary alpha-amylase (a stress biomarker) had a 29% decrease in fecundity and more than double the risk of infertility. Mindfulness-based stress reduction programs show consistent psychological benefits, and Dr. Alice Domar's Mind/Body Program found pregnancy rates of 52% in the intervention group vs. 20% in controls during IVF.
  • Mediterranean diet: Higher adherence is associated with 65 to 68% greater likelihood of IVF success. In overweight women, higher adherence to a profertility diet was associated with AMH concentrations 1.45 to 1.67 ng/mL higher than the lowest adherence group.
  • Exercise: Moderate activity (about 5 hours per week of brisk walking) was associated with shorter time to conception. Vigorous activity beyond 5 hours per week may reduce fecundity in normal-weight women.
  • Sleep: 7 to 8 hours is optimal. Women who reported difficulty falling asleep more than three times a week had significantly reduced blastocyst rates in IVF.

Real stories, real hope

Dr. John Preston Parry, a reproductive endocrinologist, shares that his own wife conceived their youngest child with an AMH of approximately 0.3, a level many would consider very low.

An RMA Network study demonstrated no difference in pregnancy rates between women with normal AMH and women with low AMH trying to conceive naturally.

Women in fertility communities regularly report conceiving naturally with AMH levels below 0.5. One documented case involved conception with an AMH of 0.01 and FSH of 150, numbers that would typically indicate primary ovarian insufficiency.

When to see a specialist

If you've been trying to conceive for 12 months (under 35) or 6 months (over 35) without success, or if you have risk factors like family history of early menopause, prior ovarian surgery, or endometriosis, it's reasonable to see a reproductive endocrinologist. A full fertility workup includes AMH alongside FSH, estradiol, antral follicle count, tubal assessment, and male factor evaluation. No single test tells the whole story.

If a provider tells you there's nothing they can do based solely on your AMH, seek a second opinion. Multiple reproductive endocrinologists emphasize that low AMH should prompt proactive planning, not hopelessness.

The emotional weight of a number

Research shows that up to 40% of women experiencing infertility carry a psychiatric diagnosis, most often depression or anxiety. A low AMH result can be emotionally devastating, especially when the clinical context isn't fully explained.

Dr. Sekhon warns that patients often receive "devastating predictions based solely on AMH without considering other fertility factors," leading to unnecessary harm. If you've received a low AMH result and are struggling emotionally, consider connecting with a fertility-focused therapist. The American Society for Reproductive Medicine recommends that all practices offering assisted reproduction have access to mental health professionals who specialize in fertility counseling.

Your AMH is one data point. It is not a verdict. Age, egg quality, overall health, and factors we don't yet fully understand all play a role in your fertility story. The science is clear: a low number does not mean the end of hope.

This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider for guidance specific to your situation.